A Massive Disruption Could Be on the Way for Marijuana: 3 Stocks Poised to Profit

What if there was a marijuana industry without marijuana? That might sound crazy, but it’s a real possibility.

There’s a lot of research under way right now to genetically engineer yeast strains to produce cannabinoids, including cannabidiol (CBD) and tetrahydrocannabinol (THC). In a nutshell, scientists are taking the genes from cannabis plants that are key in making cannabinoids and putting them into yeast.

This approach could reduce the time required to produce cannabinoids. Marijuana plants take at least three months to grow, but genetically engineered yeast can create cannabinoids in around a week. It could also be much less expensive. 

Several privately held companies are working on methods to produce high-quality cannabinoids from yeast. However, there are also a handful of publicly traded companies that are involved in this research. Here’s why Amyris (NASDAQ:AMRS), Cronos Group (NASDAQ:CRON), and OrganiGram Holdings (NASDAQOTH:OGRMF) are three stocks

... read more at: https://www.fool.com/investing/2019/03/10/a-massive-disruption-could-be-on-the-way-for-marij.aspx

by